Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Catherine Datto(General Mills (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Harald Fjällbrant(University of North Carolina at Chapel Hill), Ikuo Hirano(Northwestern University), Dominic Sinibaldi(University of North Carolina at Chapel Hill), Albert J. Bredenoord(Amsterdam Neuroscience), Kathryn A. Peterson(University of Utah), Wendy I. White(University of North Carolina at Chapel Hill), Margaret H. Collins(Cincinnati Children's Hospital Medical Center), Christopher McCrae(AstraZeneca (United States)), Julie M. Caldwell(Cincinnati Children's Hospital Medical Center), Calvin N. Ho(AstraZeneca (France)), Hanna Grindebacke(University of North Carolina at Chapel Hill), M. Keith(University of North Carolina at Chapel Hill), Laura Brooks(University of North Carolina at Chapel Hill)
Cited by 95
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
|Gastroenterology|2015|996